FineHeart is a french medical device company focused on creating innovative technologies in the cardiovascular space.
The patented FineHeart invention, the ICOMS (Implantable Cardiac Output Management System) is a novel, wirelessly powered, fully implantable mechanical circulatory support device that is able to optimize cardiac output while preserving the heart’s innate contractility. It is a game changing therapy for long term circulatory assistance in severe heart failure patients.
FineHeart was founded by a team of four internationally renowned cardiac surgeons and cardiologists, led by Dr. Stéphane Garrigue (ICOMS Inventor) and Dr. Philippe Ritter, co-inventor of cardiac resynchronization therapy, with a vision of making a miniaturized, fully implantable, pulsatile circulatory support system that would overcome many of the challenges associated with left ventricular assist devices (LVADs) currently on market. The overarching goal is to restore normal cardiac output and allow heart failure patients to return to a normal quality of life.
The founding scientists and clinicians have been joined by four managers with specific expertise in the medical device industry, led by Arnaud Mascarell (CEO).
Société anonyme à conseil d’administration au capital de 412.200 euros
Siège social :
Plateforme Technologique d’Innovation Biomédicale, Hôpital Xavier Arnozan, Avenue du Haut Lévêque, 33600 Pessac
RCS Bordeaux 519 375 356
CEO : Arnaud Mascarell
CSO : Stephane Garrigue